冠心病的临床检验中对血清胆红素及尿酸检验的价值分析
2021-12-13屈苗
屈苗

【摘 要】目的:冠心病的临床检验中对血清胆红素及尿酸检验的价值分析。方法:冠心病患者80例及同期入院体检的健康人员80例为我院2020年1月至2021年3月收治,前者为观察组,后者为对照组。两组均行尿酸以及血清胆红素检验,比较两组检查结果。结果:观察组尿酸值较对照组高,观察组不同病情程度两项指标对比差异显著(P<0.05)。结论:为冠心病患者检验尿酸及血清胆红素有利于将疾病检出。
【关键词】冠心病;临床检验;血清胆红素;尿酸
Value of serum bilirubin and uric acid in clinical examination of coronary heart disease
Qu Miao
Luan Hospital of Peking University Medical College, Shanxi Changzhi 046204,China
【Abstract】Objective: To analyze the value of serum bilirubin and uric acid in clinical test of coronary heart disease. Methods: 80 patients with coronary heart disease and 80 healthy persons admitted for physical examination in the same period were treated in our hospital from January 2020 to March 2021, the former as the observation group and the latter was the control group. Uric acid and serum bilirubin were tested in both groups, and the results were compared between the two groups. Results: The uric acid value of observation group was higher than that of control group(P<0.05). There was significant differences in the two indexes of different degrees of disease in the observation group(P<0.05). Conclusion: Testing uric acid and serum bilirubin in patients with coronary heart disease is helpful to detect the disease.
【Key?Words】Coronary heart disease; Clinical examination; Serum bilirubin; Uric acid
临床常见的心功能疾病之一即CHD(冠心病),该疾病以冠脉粥样硬化为表现,可使患者血管堵塞、狭窄,在中年、老年群体中较为常见,按照现阶段临床发病率来看,CHD有年轻化趋势[1]。患者在CHD早期临床症状并无特异性,不易引起人们重视,进而可使疾病进一步发展,对患者远期的疗效产生影响。影像学技术是临床诊断该疾病的主要方式,其中以心脏动脉造影等较为常用,但该项检查需要较高的成本,且在操作时具有一定的难度,因此不易被患者接受[2]。经临床证实,在CHD的发展中血脂異常作用明显,比如总胆固醇、低密度脂蛋白等,其含量可对患者的治疗预后产生一定影响。但CHD的唯一致病因素并非仅为血脂异常,亦有一些其他危险因素。CHD的病情程度与UA以及血清胆红素具有一定关联,前者水平与CHD疾病的进展呈正相关,后者水平与CHD疾病的发病率呈负相关。随机选取我院2020年1月至2021年3月的CHD患者、同期入院体检的健康人员共160例进行对照研究,旨在分析CHD的临床检验中UA、血清胆红素的检验价值。……
